|
Delayed
Nasdaq Stockholm
19:46:28 27/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.020 SEK | +3.80% |
|
-2.18% | +2.54% |
| 03:21pm | Irlab Therapeutics Set to Obtain US Patent for Parkinson's Disease Drug Candidate | MT |
| 10:04am | Irlab receives positive patent notice in the US for IRL1117 | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- IRLAB A Stock
- Charts IRLAB Therapeutics AB
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
















